Page last updated: 2024-09-04

vatalanib and arsenic trioxide

vatalanib has been researched along with arsenic trioxide in 1 studies

Compound Research Comparison

Studies (vatalanib)	Trials (vatalanib)	Recent Studies (post-2010) (vatalanib)	Studies (arsenic trioxide)	Trials (arsenic trioxide)	Recent Studies (post-2010) (arsenic trioxide)
276	42	98	3,119	160	1,507

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Hayashi, T; Hideshima, T	1

Reviews

1 review(s) available for vatalanib and arsenic trioxide

Article	Year
Novel therapies for multiple myeloma. British journal of haematology, 2003, Volume: 120, Issue:1 Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Enzyme Inhibitors; Estradiol; Heterocyclic Compounds, 3-Ring; Humans; Multiple Myeloma; NF-kappa B; Oxides; Phthalazines; Protease Inhibitors; Protein-Tyrosine Kinases; Pyridines; Thalidomide	2003

Article

Year

Novel therapies for multiple myeloma.

British journal of haematology, 2003, Volume: 120, Issue:1

Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Enzyme Inhibitors; Estradiol; Heterocyclic Compounds, 3-Ring; Humans; Multiple Myeloma; NF-kappa B; Oxides; Phthalazines; Protease Inhibitors; Protein-Tyrosine Kinases; Pyridines; Thalidomide

2003